全球避孕器具市場（2023-2030）：按產品和最終用戶分類的規模、佔有率、成長分析和預測

全球避孕器具市場規模將從2021年的266.8億美元成長到2022年的283億美元，預測期內年複合成長率為6.06%，預計到2030年將達到453.1億美元。

避孕技術的突破包括高效非荷爾蒙子宮內避孕器 (IUD) 的開發。這種創新裝置為女性提供了可靠、持久的避孕方法。這款子宮內避孕器具有獨特的設計，可提高安全性和易用性，最大限度地減少潛在的副作用，使其成為無憂的避孕解決方案。它的有效性和易用性使其成為尋求方便可靠的避孕方法的女性的一個有前途的選擇。

該市場也受到許多其他因素的推動，例如意外懷孕率上升、對計劃生育技術的了解和使用的增加。此外，性傳染感染的激增和政府對計劃生育計畫的資助增加也推動了市場的成長。許多避孕方法的出現，包括保險套、避孕器、口服避孕藥和皮下埋植劑，以及消費者食慾的增加，也有助於市場的擴張。此外，電子商務行業的興起、長效可逆避孕藥的開發以及產品創新也正在推動市場。同時，對非荷爾蒙避孕藥和天然避孕藥的需求不斷成長，以及女性主導的避孕技術的日益普及，兩者都在推動市場擴張。

本報告調查了全球避孕器具市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及按不同細分市場和地區進行的細分。總結了主要企業的細分、競爭形勢和概況。

目錄

• 執行摘要
• 調查方法
• 母市場分析
  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
• 關鍵市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
• 全球避孕器具市場：依產品
  • 市場概況
  • 保險套
  • 皮下植入物
  • 避孕藥
  • 避孕環
  • 隔膜
• 全球避孕器具市場：依最終用戶分類
  • 市場概況
  • 男性
  • 女士
• 全球避孕器具市場：依地區
  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭形勢
  • 前5名企業對比
  • 主要企業市場地位
  • 主要企業的招募策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率
• 主要企業簡介
  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan NV
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
  • CooperSurgical, Inc.
  • Devex
  • Mayer Laboratories, Inc.
  • Allergan plc
  • Agile Therapeutics
  • HLL Lifecare
  • ANSELL LTD
  • Mankind Pharma
  • TTK HealthCare
  • Boehringer Ingelheim International GmbH
  • V-Care Pharma Pvt. Ltd.

Global Contraceptive Devices Market size was valued at USD 26.68 billion in 2021 and is poised to grow from USD 28.3 billion in 2022 to USD 45.31 billion by 2030, growing at a CAGR of 6.06% during the forecast period (2023-2030).

To foster market growth, programs focused on reducing unintended pregnancies and associated healthcare costs and enhancing user awareness are anticipated. Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning, have been launched by governments and healthcare organizations to promote family planning and the manufacturing and utilization of contraceptives. Private and public sectors both play significant roles as providers of contraceptives. The private sector primarily supplies short-acting resupply contraceptive methods like condoms and contraceptive pills, consistently holding a considerable market share. In Asia, for instance, around 41% of females obtain contraceptives from private-sector sources, while approximately 56% rely on public sources. Across 36 evaluated countries categorized as low- and middle-income, about 63% of women acquire contraceptives from the private sector, whereas approximately 34% utilize public-sector sources.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Contraceptive Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Devices Market Segmental Analysis

Global Contraceptive Devices Market is segmented by product, end user, and region. Based on Product, the market can be segmented into condoms, subdermal implants, contraceptive drugs, vaginal rings, and diaphragms. Based on End user, the market is segmented into male and female. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Contraceptive Devices Market Dynamics

Drivers of the Global Contraceptive Devices Market

Development of a highly efficient

One groundbreaking advancement in contraceptive technology is the development of a highly efficient, non-hormonal intrauterine device (IUD). This innovative device offers women a reliable and long-lasting method of birth control. By utilizing a unique design that promotes both safety and ease of use, this IUD provides a hassle-free contraceptive solution while minimizing potential side effects. It's effectiveness and user-friendly nature make it a promising option for women seeking convenient and reliable contraception.

Restraints in the Global Contraceptive Devices

Market

Increasing risk of infections regarding the use of contraceptive devices

Contraceptive devices empower individuals to make informed choices about their reproductive health. By providing a reliable and accessible method of birth control, these devices promote reproductive autonomy and enable individuals to plan their families according to their personal circumstances. With a wide range of options available, including condoms, intrauterine devices (IUDs), and hormonal implants, contraceptive devices offer diverse choices to suit individual needs, fostering responsible sexual practices and reducing the risk of unintended pregnancies. Their availability promotes safer and healthier sexual experiences, ultimately empowering individuals to control their own reproductive journeys.

Market Trends of the Global Contraceptive Devices Key

The market is being driven by a number of factors, such as rising unwanted pregnancy rates and increased understanding and use of family planning techniques. Additionally, the soaring prevalence of STIs and the increased government financing for family planning programmes are promoting market expansion. The availability of numerous contraceptive methods, such as condoms, intrauterine devices, oral contraceptives, and subdermal implants, as well as rising consumer spending power, are also contributing to the market's expansion. In addition, the rise of the e-commerce industry, the development of long-acting reversible contraceptives, and the escalating trend of product innovations are boosting the market. This is in accordance with the growing demand for non-hormonal and natural contraceptives and the rising popularity of female-controlled contraceptive techniques, both of which are fostering market expansion.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Contraceptive Devices Market by Product
  • Market Overview
  • Condoms
  • Subdermal Implants
  • Contraceptive Drugs
  • Vaginal Rings
  • and Diaphragms
• Global Contraceptive Devices Market by End user
  • Market Overview
  • Male and Female
• Global Contraceptive Devices Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Bayer AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Janssen Global Services, LLC (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck Sharp & Dohme Corp. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mylan N.V. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Reckitt Benckiser Group plc. (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Veru Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medisafe Distribution Inc. (Canada)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • CooperSurgical, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Devex (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mayer Laboratories, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Allergan plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Agile Therapeutics (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • HLL Lifecare (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ANSELL LTD (Australia)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mankind Pharma (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • TTK HealthCare (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boehringer Ingelheim International GmbH. (Austria)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • V-Care Pharma Pvt. Ltd. (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments